CENTOGENE, the worldwide leader in using genetic knowledge to rationalize treatment decisions for rare hereditary diseases and enable patients, clinicians and pharmaceutical partners to identify and accelerate treatments for rare diseases, today announced that it will make a formal presentation at the 19th Bio€quity Europe 2018 Conference to be held May 14-16, 2018 in Ghent, Belgium.
Richard Stoffelen, Chief Financial Officer of CENTOGENE is scheduled to present on Wednesday, 16 May 2018 at 14:00 CEST.